Trials / Completed
CompletedNCT00990665
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 178 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to assess the safety and efficacy of the Quartet™ lead and Promote Q® device system in a patient population indicated for cardiac resynchronization therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CRT-D and LV lead (Quartet™ lead and Promote Q® device system) | Promote Q CRT-D and Quartet LV lead |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2010-09-01
- Completion
- 2012-07-01
- First posted
- 2009-10-07
- Last updated
- 2019-02-27
- Results posted
- 2019-02-27
Locations
24 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00990665. Inclusion in this directory is not an endorsement.